文献速递哮喘呼吸道感染

婴儿重症毛细支气管炎的鼻气道microRNA谱与儿童哮喘风险:多中心前瞻性研究

Nasal airway microRNA profiling of infants with severe bronchiolitis and risk of childhood asthma: a multicentre prospective study.
PubMed 文献 · Eur Respir J · 2023-08-03

该17中心前瞻性队列对575例重症毛细支气管炎婴儿住院时鼻microRNA测序,发现23个与6岁前哮喘发生相关的差异表达microRNA,尤其在呼吸道合胞病毒感染婴儿中显著,并关联哮喘相关临床特征、免疫细胞表达及通路。

要点

  • 重症毛细支气管炎婴儿鼻miRNA谱与6岁前哮喘风险相关。
  • 23个差异表达miRNA与哮喘发生相关,RSV感染婴儿中交互显著。
  • 这些miRNA关联湿疹、激素使用等哮喘相关特征及免疫通路。

核心结论

  • 重症毛细支气管炎婴儿鼻miRNA与主要哮喘相关临床特征、免疫反应及哮喘发生风险相关。

研究设计与样本

  • 17中心前瞻性队列研究,纳入575例重症毛细支气管炎婴儿,住院时鼻microRNA测序,中位年龄3个月。

主要发现

  • 鉴定出23个与6岁前哮喘发生相关的差异表达miRNA(如hsa-miR-29a-3p;FDR<0.10)。
  • RSV感染婴儿中交互作用FDR<0.05。
  • 差异表达miRNA与16个哮喘相关临床特征相关(FDR<0.05),如婴儿湿疹和住院期间皮质类固醇使用。
  • 差异表达miRNA在肺组织和免疫细胞(如辅助T细胞、中性粒细胞)中高表达。
  • 差异表达miRNA与其mRNA靶标负相关(如hsa-miR-324-3p/IL13),富集于Toll样受体、PI3K-Akt和FcɛR信号通路(FDR<0.05),并经细胞因子数据验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe bronchiolitis (i.e. bronchiolitis requiring hospitalisation) during infancy is a major risk factor for childhood asthma. However, the exact mechanism linking these common conditions remains unclear. We examined the longitudinal relationship between nasal airway miRNAs during severe bronchiolitis and the risk of developing asthma. METHODS: In a 17-centre prospective cohort study of infants with severe bronchiolitis, we sequenced their nasal microRNA at hospitalisation. First, we identified differentially expressed microRNAs (DEmiRNAs) associated with the risk of developing asthma by age 6 years. Second, we characterised the DEmiRNAs based on their association with asthma-related clinical features, and expression level by tissue and cell types. Third, we conducted pathway and network analyses by integrating DEmiRNAs and their mRNA targets. Finally, we investigated the association of DEmiRNAs and nasal cytokines. RESULTS: In 575 infants (median age 3 months), we identified 23 DEmiRNAs associated with asthma development (e.g. hsa-miR-29a-3p; false discovery rate (FDR) <0.10), particularly in infants with respiratory syncytial virus infection (FDR for the interaction <0.05). These DEmiRNAs were associated with 16 asthma-related clinical features (FDR <0.05), e.g. infant eczema and corticosteroid use during hospitalisation. In addition, these DEmiRNAs were highly expressed in lung tissue and immune cells (e.g. T-helper cells, neutrophils). Third, DEmiRNAs were negatively correlated with their mRNA targets (e.g. hsa-miR-324-3p/IL13), which were enriched in asthma-related pathways (FDR <0.05), e.g. toll-like receptor, PI3K-Akt and FcɛR signalling pathways, and validated by cytokine data. CONCLUSION: In a multicentre cohort of infants with severe bronchiolitis, we identified nasal miRNAs during illness that were associated with major asthma-related clinical features, immune response, and risk of asthma development.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Zhu Z, Freishtat RJ, Harmon B, et al. Nasal airway microRNA profiling of infants with severe bronchiolitis and risk of childhood asthma: a multicentre prospective study. Eur Respir J. 2023. PMID: 37321621. doi:10.1183/13993003.00502-2023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。